Xcopri

Active Ingredient(s): Cenobamate
FDA Approved: * November 21, 2019
Pharm Company: * SK LIFE SCIENCE INC
Category: Anticonvulsant

Cenobamate, sold under the brand names Xcopri (US) and Ontozry (EU), is a medication used for the treatment of partial-onset seizures, a kind of epilepsy, in adults. It is taken by mouth.[1][4][5] Cenobamate was approved for medical use in the United States in November 2019[1][4][5][6] and placed in Schedule V of the Controlled Substances Act in March 2020.[7] Cenoba... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xcopri 25 mg Oral Tablet, Film Coated
NDC: 71699-025
Labeler:
Sk Life Science, Inc.
Xcopri 50 mg Oral Tablet, Film Coated
NDC: 71699-050
Labeler:
Sk Life Science, Inc.
Xcopri 100 mg Oral Tablet, Film Coated
NDC: 71699-100
Labeler:
Sk Life Science, Inc.
Xcopri 150 mg Oral Tablet, Film Coated
NDC: 71699-150
Labeler:
Sk Life Science, Inc.
Xcopri 200 mg Oral Tablet, Film Coated
NDC: 71699-200
Labeler:
Sk Life Science, Inc.